Literature DB >> 18307264

Cataplexy features in childhood narcolepsy.

Leonardo Serra1, Pasquale Montagna, Emmanuel Mignot, Elio Lugaresi, Giuseppe Plazzi.   

Abstract

Cataplexy, the hallmark of narcolepsy, has been well characterized in adults but not in children. This study systematically used structured clinical assessments and video-recordings (49 episodes in eight cases) to evaluate cataplexy in 23 patients diagnosed before the age of 18 years. Forty-three percent of patients had falls as part of their attacks. During cataplexy knees, head, and jaw were the most frequently compromised body segments; eyelids, arms, and trunk being less commonly involved. More rarely, blurred vision, slurred speech, irregular breathing, or a sudden loss of smiling mimics were reported. One-third of the sample presented with a previously unrecognized description of cataplexy that we coined "cataplectic facies," consisting of a state of semipermanent eyelid and jaw weakness, on which partial or complete cataplectic attacks were superimposed. The usual triggering emotions, such as laughter, joking, or anger, were not always present, especially when close to an abrupt onset, hampering diagnosis. Video-recordings of cataplectic attacks may be useful to document the attack, allowing a comparison with archived presentations. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18307264     DOI: 10.1002/mds.21965

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

1.  Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.

Authors:  Stine Knudsen; Poul J Jennum; Jørgen Alving; Søren Paludan Sheikh; Steen Gammeltoft
Journal:  Sleep       Date:  2010-02       Impact factor: 5.849

2.  Sleep dynamics beyond traditional sleep macrostructure.

Authors:  Giuseppe Plazzi; Fabio Pizza
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

3.  Narcolepsy Type 1 and Idiopathic Generalized Epilepsy: Diagnostic and Therapeutic Challenges in Dual Cases.

Authors:  Simone Baiardi; Stefano Vandi; Fabio Pizza; Lara Alvisi; Lucia Toscani; Elena Zambrelli; Paolo Tinuper; Geert Mayer; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

Review 4.  The diagnosis and treatment of pediatric narcolepsy.

Authors:  Sona Nevsimalova
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

5.  [Narcolepsy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

6.  Presentations of primary hypersomnia in Chinese children.

Authors:  Fang Han; Ling Lin; Jing Li; Adi Aran; Song X Dong; Pei An; Long Zhao; Ming Li; Qian Y Li; Han Yan; Jie S Wang; Hui Y Gao; Mei Li; Zhan C Gao; Kingman P Strohl; Emmanuel Mignot
Journal:  Sleep       Date:  2011-05-01       Impact factor: 5.849

7.  Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy.

Authors:  Kiran Maski; Erin Steinhart; David Williams; Thomas Scammell; Julie Flygare; Kimberly McCleary; Monica Gow
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

8.  Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.

Authors:  Christian R Baumann; Emmanuel Mignot; Gert Jan Lammers; Sebastiaan Overeem; Isabelle Arnulf; David Rye; Yves Dauvilliers; Makoto Honda; Judith A Owens; Giuseppe Plazzi; Thomas E Scammell
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

9.  A consensus definition of cataplexy in mouse models of narcolepsy.

Authors:  Thomas E Scammell; Jon T Willie; Christian Guilleminault; Jerome M Siegel
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

10.  Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.

Authors:  Giuseppe Plazzi; Francesca Poli; Christian Franceschini; Antonia Parmeggiani; Piero Pirazzoli; Filippo Bernardi; Emmanuel Mignot; Alessandro Cicognani; Pasquale Montagna
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.